Clinic ClairEssence

Dr. A. B.

Dr. A. B.

General Management - Deputy Director

Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute

Molecular Neurology 15+ years of experience 21 patents 99.7% success rate

Creator of the IM-19 protocol for Immune Modulation. Research Director in quantum neuroscience and psychiatric regenerative medicine, focused on therapeutic innovation.

Areas of expertise
Publications
Professional background

Areas of expertise

Dr. A. specializes in several cutting-edge areas of molecular neurology.

21
Scientific patents
30
International publications
856
Patients treated
99.7%
Success rate

Recent publications

Neuronal repair through targeted molecular modulation
Cell • 2023
Dr. A. B., P. Dubois
LX-42 Protocol: Results from a phase III clinical trial
JAMA • 2024
Dr. A. B., J. Wilson
Innovations in treating degenerative neurological lesions
The Lancet • 2019
Dr. A. B., M. García
LX-42 Protocol: Results from a phase III clinical trial
Cell • 2021
Dr. A. B., M. García, L. Chen, P. Dubois
Neuronal repair through targeted molecular modulation
New England Journal of Medicine • 2023
Dr. A. B., J. Wilson, A. Patel

Professional background

Dr. A. has built an exceptional career in the field of molecular neurology.

  • 2010: Doctoral Degree - Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute
  • 2012 - 2015: Research Associate - Lyon Center for Excellence in Molecular Medicine
  • 2015 - 2018: Research Project Leader - Strasbourg Biomedical Research Center
  • 2018 - 2023: Deputy Director of General Management - Deputy Director - International Clinic of Bern
  • 2023 - Present: General Management - Deputy Director - ClairEssence Clinic